HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Biological gel-based microchamber array for tumor cell proliferation and migration studies in well-controlled biochemical gradients.

Abstract
Breast cancer metastasis is a complex process controlled by multiple factors, including various cell-cell interactions, cell-environment coupling, and oxygen, nutrient and drug gradients that are intimately related to the heterogeneous breast tissue structure. In this study, we constructed a high-throughput in vitro biochip system containing an array of 642 microchambers arranged in a checkerboard configuration, with each chamber embedded in a composite extracellular matrix (ECM) composed of engineered collagen and Matrigel to mimic local heterogeneous environment in vivo. In addition, a controllable complex tetragonal chemical concentration profile can be achieved by imposing chemical compounds at the four boundaries of the chip, leading to distinct local nutrient and/or drug gradients in the individual microchambers. Here, the microchamber array with composite ECM (MACECM) device aims to simulate multiple tumor cell niches composed of both breast epithelial cells (MCF-10A-GFP) and metastatic breast cancer cells (MDA-MB-231-RFP), which enables systematic studies of cell responses to a variety of biochemical conditions. The results obtained from the MACECM studies indicate that discoidin domain receptor 1 (DDR1) inhibitor 7rh and matrix metalloproteinase inhibitor batimastat, in association with epidermal growth factor (EGF) had no significant effects on the growth of MCF-10A-GFP cells, but had significant effects on DDR1 expression and the related migratory behavior of MDA-MB-231-RFP cells. The MACECM design not only enables the construction of a more realistic in vitro model for investigating cancer cell migration mechanisms but also has considerable potential for further development as a platform for next-generation high-throughput and therapeutic screening (e.g., anti-cancer drug evaluation) and personalized medicine.
AuthorsJingru Yao, Guoqiang Li, Yang Jiao, Yu Zheng, Yanping Liu, Gao Wang, Lianjie Zhou, Hongfei Zhang, Xianquan Zhang, Jianwei Shuai, Qihui Fan, Fangfu Ye, Silong Lou, Guo Chen, Kena Song, Yong Liao, Liyu Liu
JournalLab on a chip (Lab Chip) Vol. 21 Issue 15 Pg. 3004-3018 (08 07 2021) ISSN: 1473-0189 [Electronic] England
PMID34159958 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Breast Neoplasms (drug therapy)
  • Cell Line, Tumor
  • Cell Movement
  • Cell Proliferation
  • Epithelial Cells
  • Extracellular Matrix
  • Female
  • Humans

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: